{"id":13739,"date":"2018-01-05T11:37:22","date_gmt":"2018-01-05T11:37:22","guid":{"rendered":"https:\/\/celonpharma.com\/?p=13739"},"modified":"2018-02-20T13:12:22","modified_gmt":"2018-02-20T13:12:22","slug":"celonko","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/celonko\/","title":{"rendered":"CELONKO"},"content":{"rendered":"
\"\"<\/div>\n

 <\/p>\n

CELONKO \u2013 “Development of modern biomarkers and development of an innovative FGFR kinases inhibitor” <\/strong><\/h2>\n

\u2013 the project received co-financing from the National Centre for Research and Development in the amount of PLN 39,025,710\u00a0under THE PROGRAMME OF SCIENTIFIC RESEARCH AND DEVELOPMENT entitled STRATEGMED \u201cPROPHYLAXYS AND TREATMENT OF DISEASES OF AFFLUENCE\u201d.<\/p>\n

For many years Celon Pharma has been developing projects targeting selected cancer paths. CELONKO, with its objective being preclinical and clinical development of a new anti-cancer drug targeting fibroblast growth factor receptors (FGFRs), fits well into this scope of activities. As a result of R&D works, a selective, small-molecule FGFR inhibitor will be obtained.\u00a0It will be possible to use this drug in the fight against stomach cancer, bladder cancer and in treatment of squamous cell lung cancer. Subsequent stages of the project will include the development of a diagnostic test for identifying patients with FGFR receptor aberrations. This will allow for selecting the patients who would benefit most from a personalised therapy based on a selective FGFR inhibitor.
\nThe project is implemented by a scientific-business consortium led by Celon Pharma along with the National Research Institute for Tuberculosis and Lung Diseases in Warsaw, the Military Institute of Medicine in Warsaw, the Maria Sk\u0142odowska-Curie Institute of Oncology in Warsaw and the Medical University of Gda\u0144sk. The scientific institutions are responsible for the search for molecular pathways and diagnostic methods and their facilities will also carry out the clinical part of the project. Celon Pharma, as the consortium leader, is responsible for the issues related to regulation, quality and pharmaceutical aspects, as well as coordination of clinical trials conducted with the objective of obtaining the FGFR inhibitor.<\/p>\n

Total value of the project:<\/strong>\u00a0PLN 54,717125<\/p>\n","protected":false},"excerpt":{"rendered":"

  CELONKO \u2013 “Development of modern biomarkers and development of an innovative FGFR kinases inhibitor”<\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[53],"tags":[],"class_list":["post-13739","post","type-post","status-publish","format-standard","hentry","category-pl-co-financed-projects-implemented"],"acf":[],"yoast_head":"\nCELONKO - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/celonko\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CELONKO - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"  CELONKO \u2013 “Development of modern biomarkers and development of an innovative FGFR kinases inhibitor”\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/celonko\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2018-01-05T11:37:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-02-20T13:12:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/celonpharma.com\/wp-content\/uploads\/2018\/01\/pasek-celonko-note.jpg\" \/>\n<meta name=\"author\" content=\"S\u0142awomir Ni\u017cnik\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"S\u0142awomir Ni\u017cnik\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celonko\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celonko\\\/\"},\"author\":{\"name\":\"S\u0142awomir Ni\u017cnik\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\"},\"headline\":\"CELONKO\",\"datePublished\":\"2018-01-05T11:37:22+00:00\",\"dateModified\":\"2018-02-20T13:12:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celonko\\\/\"},\"wordCount\":285,\"image\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celonko\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/pasek-celonko-note.jpg\",\"articleSection\":[\"PL - co-financed projects implemented\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celonko\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celonko\\\/\",\"name\":\"CELONKO - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celonko\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celonko\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/pasek-celonko-note.jpg\",\"datePublished\":\"2018-01-05T11:37:22+00:00\",\"dateModified\":\"2018-02-20T13:12:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celonko\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/celonko\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celonko\\\/#primaryimage\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/pasek-celonko-note.jpg\",\"contentUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/pasek-celonko-note.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celonko\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CELONKO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\",\"name\":\"S\u0142awomir Ni\u017cnik\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CELONKO - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/celonko\/","og_locale":"en_US","og_type":"article","og_title":"CELONKO - Celon Pharma","og_description":"  CELONKO \u2013 “Development of modern biomarkers and development of an innovative FGFR kinases inhibitor”","og_url":"https:\/\/celonpharma.com\/en\/celonko\/","og_site_name":"Celon Pharma","article_published_time":"2018-01-05T11:37:22+00:00","article_modified_time":"2018-02-20T13:12:22+00:00","og_image":[{"url":"https:\/\/celonpharma.com\/wp-content\/uploads\/2018\/01\/pasek-celonko-note.jpg","type":"","width":"","height":""}],"author":"S\u0142awomir Ni\u017cnik","twitter_card":"summary_large_image","twitter_misc":{"Written by":"S\u0142awomir Ni\u017cnik","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/celonko\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/celonko\/"},"author":{"name":"S\u0142awomir Ni\u017cnik","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338"},"headline":"CELONKO","datePublished":"2018-01-05T11:37:22+00:00","dateModified":"2018-02-20T13:12:22+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/celonko\/"},"wordCount":285,"image":{"@id":"https:\/\/celonpharma.com\/en\/celonko\/#primaryimage"},"thumbnailUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2018\/01\/pasek-celonko-note.jpg","articleSection":["PL - co-financed projects implemented"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/celonko\/","url":"https:\/\/celonpharma.com\/en\/celonko\/","name":"CELONKO - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/celonpharma.com\/en\/celonko\/#primaryimage"},"image":{"@id":"https:\/\/celonpharma.com\/en\/celonko\/#primaryimage"},"thumbnailUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2018\/01\/pasek-celonko-note.jpg","datePublished":"2018-01-05T11:37:22+00:00","dateModified":"2018-02-20T13:12:22+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/celonko\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/celonko\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/celonpharma.com\/en\/celonko\/#primaryimage","url":"https:\/\/celonpharma.com\/wp-content\/uploads\/2018\/01\/pasek-celonko-note.jpg","contentUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2018\/01\/pasek-celonko-note.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/celonko\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"CELONKO"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338","name":"S\u0142awomir Ni\u017cnik"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/13739","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=13739"}],"version-history":[{"count":3,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/13739\/revisions"}],"predecessor-version":[{"id":14590,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/13739\/revisions\/14590"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=13739"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=13739"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=13739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}